HealthlineNews
Sep 29 2014
Breast Cancer Drug Perjeta Extends Survival by Nearly 16 Months
Final results of a large clinical trial indicate that Genentech's antibody Perjeta dramatically inc...  Read More»
Sep 28 2014
Sep 27 2014
Topics:  Diabetes
Sep 26 2014
Topics:  Arthritis
Sep 25 2014
Topics:  Cancer
Sep 24 2014
Topics:  Women's Health
Sep 24 2014
Sep 23 2014
Topics:  General Health
Sep 22 2014
Topics:  HIV
Sep 18 2014
Topics:  Cold and Flu
Sep 17 2014
Topics:  Multiple Sclerosis
Sep 17 2014
Topics:  HIV | Men's Health
Sep 16 2014
Topics:  COPD
Sep 15 2014
Sep 15 2014
Sep 15 2014
Sep 14 2014
Topics:  Arthritis
Sep 13 2014
Topics:  Cancer | Women's Health
Sep 12 2014
Topics:  HIV
Sep 10 2014
Topics:  Multiple Sclerosis
Sep 10 2014
Topics:  Cancer | Skin Conditions
Sep 08 2014
Topics:  Cancer
Advertisement